{"id":324708,"date":"2026-10-22T16:00:05","date_gmt":"2026-10-22T10:30:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/beta-drugs-q2-results-fy27-pat-19-crore\/"},"modified":"2026-10-22T16:01:35","modified_gmt":"2026-10-22T10:31:35","slug":"beta-drugs-q2-results-fy27-pat-19-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/beta-drugs-q2-results-fy27-pat-19-crore\/","title":{"rendered":"Beta Drugs Q2 Results FY27: PAT Jumps 51.8% to Rs 18.55 Cr, Revenue Rs 137.49 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Beta Drugs Q2 Results FY27 were declared on 22 October 2026, and the quarterly results showed revenue of Rs 137.49 Cr with 32.98% YoY growth. Net profit stood at Rs 18.55 Cr, up 51.8% YoY growth, reflecting a stronger second quarter on a year-on-year basis. The results were announced for Q2 FY27 as part of the company\u2019s quarterly results update.<\/p>\n<\/div>\n

Beta Drugs Ltd<\/a> (BETA) Q2 Results FY27 announced on 22 October 2026, covering the company’s financial performance for the July to September 2026 quarter. Beta Drugs Q2 Results FY27 showed revenue of Rs 137.49 Cr versus Rs 103.39 Cr a year earlier, while net profit increased to Rs 18.55 Cr from Rs 12.22 Cr. The results date is 22 October 2026, and the article below follows the disclosed numbers for this results date.<\/p>\n

Beta Drugs Q2 Results FY27 are best read as a results analysis of the reported revenue, the profit line and net profit, with no extra assumptions added. This note breaks the quarter into financial highlights, business drivers, outlook and risks, then hands over to the Financial Highlights.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n